Papillary Renal Cell Carcinoma

general

Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas. It can be hereditary or sporadic. The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y. The peak incidence is in the sixth and seven decades. It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell

Centers

124

Active Trials

$3.3B

Cancer Funding

Specific Cancer Types(3)

Name	Centers	Active Trials
Type 1 Papillary Renal Cell Carcinoma	49	—
Type 2 Papillary Renal Cell Carcinoma	49	—
Sporadic Papillary Renal Cell Carcinoma	7	7

Top Centers for Papillary Renal Cell Carcinoma(77)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive High-Volume Research Center	High-Volume Research Center	2	$977K	74.9
2	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center	High-Volume Research Center	5	—	72.0
3	University of Illinois Cancer CenterChicago, IL High-Volume Research Center	High-Volume Research Center	5	—	72.0
4	Cancer Center at IllinoisUrbana, IL High-Volume Research Center	High-Volume Research Center	5	—	72.0
5	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	3	—	69.0
6	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	3	—	69.0
7	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program	Active Research Program	3	—	69.0
8	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	3	—	69.0
9	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	4	—	69.0
10	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program	Active Research Program	3	—	69.0
11	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
12	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
13	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
14	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
15	UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program	Active Research Program	3	—	57.4
16	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
17	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
18	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
19	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	3	—	57.4
20	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
21	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
22	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
23	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
24	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	2	—	57.4
25	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	2	—	57.4
26	UMass Memorial Health Cancer CenterWorcester, MA Active Research Program	Active Research Program	2	—	57.4
27	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	2	—	57.4
28	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	2	—	57.4
29	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program	Active Research Program	3	—	57.4
30	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program	Active Research Program	2	—	57.4
31	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	2	—	57.4
32	Penn State Cancer InstituteHershey, PA Active Research Program	Active Research Program	2	—	57.4
33	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	2	—	57.4
34	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	2	—	57.4
35	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	2	—	57.4
36	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR Active Research Program	Active Research Program	2	—	57.4
37	Upstate Cancer CenterSyracuse, NY Active Research Program	Active Research Program	2	—	57.4
38	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	2	—	57.4
39	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
40	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
41	UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
42	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
43	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
44	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
45	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
46	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
47	UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program	Active Research Program	1	—	38.2
48	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
49	Cedars-Sinai CancerLos Angeles, CA Active Research Program	Active Research Program	1	—	38.2
50	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	1	—	38.2
51	Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
52	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
53	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
54	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program	Active Research Program	1	—	38.2
55	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
56	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program	Active Research Program	1	—	38.2
57	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	1	—	38.2
58	Stony Brook Cancer CenterStony Brook, NY Active Research Program	Active Research Program	1	—	38.2
59	Livestrong Cancer InstitutesAustin, TX Active Research Program	Active Research Program	1	—	38.2
60	Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program	Active Research Program	1	—	38.2
61	The University of Vermont Cancer CenterBurlington, VT Active Research Program	Active Research Program	1	—	38.2
62	Northwell Health Cancer InstituteNew York, NY Active Research Program	Active Research Program	1	—	38.2
63	University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program	Active Research Program	1	—	38.2
64	Loma Linda University Cancer CenterLoma Linda, CA Active Research Program	Active Research Program	1	—	38.2
65	BC CancerVancouver, BC Active Research Program	Active Research Program	1	—	38.2
66	Tampa General Hospital Cancer InstituteTampa, FL Active Research Program	Active Research Program	1	—	38.2
67	Princess Margaret Cancer CentreToronto, ON Active Research Program	Active Research Program	1	—	38.2
68	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive		—	—	28.3
69	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive		—	$754M	—
70	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive		—	$737M	—
71	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive		—	$368M	—
72	OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive		—	$354M	—
73	Moffitt Cancer CenterTampa, FL NCI Comprehensive		—	$296M	—
74	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive		—	$276M	—
75	Montefiore Einstein Comprehensive Cancer CenterBronx, NY NCI Comprehensive		—	$246M	—
76	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive		—	$216M	—
77	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive		—	$103M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →